BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 32416701)

  • 21. Anticancer activity, dual prooxidant/antioxidant effect and apoptosis induction profile of new bichalcophene-5-carboxamidines.
    Ismail MA; Negm A; Arafa RK; Abdel-Latif E; El-Sayed WM
    Eur J Med Chem; 2019 May; 169():76-88. PubMed ID: 30856408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.
    Nan X; Li HJ; Fang SB; Li QY; Wu YC
    Eur J Med Chem; 2020 May; 193():112241. PubMed ID: 32200199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [1,2,4]Triazolo[4,3-c]quinazoline and bis([1,2,4]triazolo)[4,3-a:4',3'-c]quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies.
    El-Adl K; Ibrahim MK; Alesawy MSI; Eissa IH
    Bioorg Med Chem; 2021 Jan; 30():115958. PubMed ID: 33360576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and cytotoxic evaluation of novel furo[2,3-b]quinoline derivatives.
    Wang B; Li Q; Shi W; Chen L; Sun J
    Chem Biol Drug Des; 2018 Apr; 91(4):957-961. PubMed ID: 29197162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine mediated pyrazolo-quinoline derivatives as potent anti-proliferative agents.
    Kasaboina S; Ramineni V; Banu S; Bandi Y; Nagarapu L; Dumala N; Grover P
    Bioorg Med Chem Lett; 2018 Feb; 28(4):664-667. PubMed ID: 29409753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
    Nasr EE; Mostafa AS; El-Sayed MAA; Massoud MAM
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800355. PubMed ID: 31081954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study.
    El-Husseiny WM; El-Sayed MA; Abdel-Aziz NI; El-Azab AS; Ahmed ER; Abdel-Aziz AA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):507-518. PubMed ID: 29455554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of new series of hexahydroquinoline and fused quinoline derivatives as potent inhibitors of wild-type EGFR and mutant EGFR (L858R and T790M).
    Shaheen MA; El-Emam AA; El-Gohary NS
    Bioorg Chem; 2020 Dec; 105():104274. PubMed ID: 33339080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antileishmanial activity of novel pyridinium-hydrazone derivatives.
    Alptuzun V; Cakiroglu G; Limoncu ME; Erac B; Hosgor-Limoncu M; Erciyas E
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):960-7. PubMed ID: 22803671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a novel series of substituted quinolines acting as anticancer agents and selective EGFR blocker: Molecular docking study.
    Kumar CBP; Raghu MS; Prathibha BS; Prashanth MK; Kanthimathi G; Kumar KY; Parashuram L; Alharthi FA
    Bioorg Med Chem Lett; 2021 Jul; 44():128118. PubMed ID: 34015505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel selenadiazole derivatives as selective antitumor and radical scavenging agents.
    Ruberte AC; Plano D; Encío I; Aydillo C; Sharma AK; Sanmartín C
    Eur J Med Chem; 2018 Sep; 157():14-27. PubMed ID: 30071406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. β-Sitosterol from Ifloga spicata (Forssk.) Sch. Bip. as potential anti-leishmanial agent against leishmania tropica: Docking and molecular insights.
    Majid Shah S; Ullah F; Ayaz M; Sadiq A; Hussain S; Ali Shah AU; Adnan Ali Shah S; Wadood A; Nadhman A
    Steroids; 2019 Aug; 148():56-62. PubMed ID: 31085212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microwave-assisted synthesis of novel 5-substituted benzylidene amino-2-butyl benzofuran-3-yl-4-methoxyphenyl methanones as antileishmanial and antioxidant agents.
    Patil SR; Bollikonda S; Patil RH; Sangshetti JN; Bobade AS; Asrondkar A; Reddy PP; Shinde DB
    Bioorg Med Chem Lett; 2018 Feb; 28(3):482-487. PubMed ID: 29258770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
    Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
    Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro anti-leishmanial activity of Prunus armeniaca fractions on Leishmania tropica and molecular docking studies.
    Shaheen N; Qureshi NA; Ashraf A; Hamid A; Iqbal A; Fatima H
    J Photochem Photobiol B; 2020 Dec; 213():112077. PubMed ID: 33220600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
    Martínez-Muñoz A; Prestegui-Martel B; Méndez-Luna D; Fragoso-Vázquez MJ; García-Sánchez JR; Bello M; Martínez-Archundia M; Chávez-Blanco A; Dueñas-González A; Mendoza-Lujambio I; Trujillo-Ferrara J; Correa-Basurto J
    Anticancer Agents Med Chem; 2018; 18(11):1629-1638. PubMed ID: 29745344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological evaluation of some new fluorine containing hydroxypyrazolines as potential anticancer and antioxidant agents.
    Dinesha ; Viveka S; Priya BK; Pai KS; Naveen S; Lokanath NK; Nagaraja GK
    Eur J Med Chem; 2015 Nov; 104():25-32. PubMed ID: 26433616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and in vitro anticancer activity of novel quinoline and oxadiazole derivatives of ursolic acid.
    Gu W; Jin XY; Li DD; Wang SF; Tao XB; Chen H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4128-4132. PubMed ID: 28733083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and screening of thiosemicarbazide-dithiocarbamate conjugates for antioxidant and anticancer activities.
    Icharam Narkhede H; Shridhar Dhake A; Rikhabchand Surana A
    Bioorg Chem; 2022 Jul; 124():105832. PubMed ID: 35500502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and antitumor evaluation of quinoline-imidazole derivatives.
    Xiao Z; Lei F; Chen X; Wang X; Cao L; Ye K; Zhu W; Xu S
    Arch Pharm (Weinheim); 2018 Jun; 351(6):e1700407. PubMed ID: 29732607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.